University of Toledo, Health Science Campus
Toledo, Ohio, United States
Medical school in Toledo, Ohio
3000 Arlington Ave, Toledo, OH 43614
About University of Toledo, Health Science Campus
The University of Toledo College of Medicine and Life Sciences is a medical school affiliated with the University of Toledo, a public university located in Toledo, Ohio, United States. The College is located on the University of Toledo's Health Science Campus in south Toledo.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Toledo Health Science Campus
17
Novartis
2
Bial - Portela C S.A.
1
National Institute of Allergy and Infectious Diseases (NIAID)
1
Novartis Pharmaceuticals
1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1
Shashi Bhatt, MD
1
Sucampo Pharma Americas, LLC
1
Sunovion
1
ViiV Healthcare
1
Clinical Trials at University of Toledo, Health Science Campus
During the past decade, University of Toledo, Health Science Campus conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 9 clinical trials were completed, i.e. on
average, 450% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis
2006-06-01
2011-08-01
Completed
1,083
Assessment of Low Level Laser Therapy for Late Postoperative Pain After Lumbar Fusion Surgery
2006-12-01
2010-12-01
Withdrawn
0
Assessment Of Infrared Photobiotherapy for Improved Wound Healing
2007-01-01
2011-05-01
Completed
50
Expanded Access Program for Maraviroc At Multiple Centers
2007-02-01
2010-06-01
Completed
1,047
Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation
2007-01-01
Completed
124
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University of Toledo, Health Science Campus" #1 sponsor was "University of Toledo Health Science Campus" with 17 trials, followed by "Novartis" with 2 trials
sponsored, "Bial - Portela C S.A." with 1 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials sponsored and "Novartis Pharmaceuticals"
with 1 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Toledo, Health Science Campus"
#1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator, "National Institute on Aging (NIA)" with 1 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at University of Toledo, Health Science Campus
According to Clinical.Site data, the most researched conditions in "University of Toledo, Health Science Campus" are
"Diabetes" (2 trials), "Epilepsy" (2 trials), "Multiple Sclerosis" (2 trials), "Muscle Relaxants" (2 trials) and "Pneumococcal Infection" (2 trials). Many other conditions were trialed in "University of Toledo, Health Science Campus" in a lesser frequency.
Clinical Trials Intervention Types at University of Toledo, Health Science Campus
Most popular intervention types in "University of Toledo, Health Science Campus" are "Drug" (12 trials), "Device" (5 trials), "Biological" (4 trials), "Other" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Low Level Laser Therapy" (2 trials), "1200 mg QD Eslicarbazepine acetate" (1 trials), "13-valent pneumococcal conjugate vaccine" (1 trials) and "23-valent pneumococcal polysaccharide vaccine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of Toledo, Health Science Campus
The vast majority of trials in "University of Toledo, Health Science Campus" are
26 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at University of Toledo, Health Science Campus
Currently, there are NaN active trials in "University of Toledo, Health Science Campus".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 19 completed trials in University of Toledo, Health Science Campus,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in University of Toledo, Health Science Campus, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 8 trials that are defined as “Not Applicable".